Companies › IMNN
Imunon Inc (IMNN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000749647 · EDGAR filings · Updated 2026-07-21
Imunon Inc (IMNN) has reported institutional ownership of 12.8%, with 19 institutional managers holding positions valued at $1.63M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-21 — Insider transaction reported (Form 4)
- 2026-07-21 — Insider transaction reported (Form 4)
- 2026-07-21 — Insider transaction reported (Form 4)
- 2026-07-21 — Insider transaction reported (Form 4)
- 2026-07-07 — Insider transaction reported (Form 4)
- 2026-07-07 — Initial insider ownership filed (Form 3)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Imunon Inc has 19 institutional holders and institutional ownership of 12.8%.
Insider activity
Insiders reported 5 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
APREA THERAPEUTICS INC (APRE) · REGENTIS BIOMATERIALS LTD (RGNT) · Retractable Technologies Inc (RVP) · PLUS THERAPEUTICS INC (PSTV) · Turn Therapeutics Inc (TTRX) · BioVie Inc (BIVI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.